279 related articles for article (PubMed ID: 33213474)
1. Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs).
Lunt LE; Shoop-Worrall S; Smith N; Cleary G; McDonagh J; Smith AD; Thomson W; McErlane F
Pediatr Rheumatol Online J; 2020 Nov; 18(1):91. PubMed ID: 33213474
[TBL] [Abstract][Full Text] [Related]
2. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
McErlane F; Foster HE; Armitt G; Bailey K; Cobb J; Davidson JE; Douglas S; Fell A; Friswell M; Pilkington C; Strike H; Smith N; Thomson W; Cleary G
Rheumatology (Oxford); 2018 Jan; 57(1):140-151. PubMed ID: 29069424
[TBL] [Abstract][Full Text] [Related]
3. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
McErlane F; Armitt G; Cobb J; Bailey K; Cleary G; Douglas S; Lunt L; Rashid A; Sampath S; Shoop-Worrall S; Smith N; Foster H; Thomson W
Rheumatology (Oxford); 2020 Jan; 59(1):137-145. PubMed ID: 31243450
[TBL] [Abstract][Full Text] [Related]
4. PROMs and PREMs in routine perinatal care: mixed methods evaluation of their implementation into integrated obstetric care networks.
Depla AL; Pluut B; Lamain-de Ruiter M; Kersten AW; Evers IM; Franx A; Bekker MN
J Patient Rep Outcomes; 2023 Mar; 7(1):26. PubMed ID: 36894797
[TBL] [Abstract][Full Text] [Related]
5. Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands.
Beckers E; Webers C; Boonen A; Ten Klooster PM; Vonkeman HE; van Tubergen A
Clin Rheumatol; 2020 Oct; 39(10):2889-2897. PubMed ID: 32318970
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Patient-Reported Outcome Measures (PROM) and Patient-Reported Experience Measures (PREM) in Home Respiratory Therapies: Oxygen Therapy, CPAP Treatment, Mechanical Ventilation, and Aerosol Therapy.
Rudilla D; Moros V; Lalanza S; Galiana L; Hass N; Vergara I; Bezos C; Ancochea J; Landete P
Open Respir Arch; 2021; 3(4):100132. PubMed ID: 37496843
[TBL] [Abstract][Full Text] [Related]
7. The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Boyko Y; Hrytsiuk I; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):403-409. PubMed ID: 29637352
[TBL] [Abstract][Full Text] [Related]
8. Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings.
Stover AM; Haverman L; van Oers HA; Greenhalgh J; Potter CM;
Qual Life Res; 2021 Nov; 30(11):3015-3033. PubMed ID: 32651805
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study to identify thematic areas for HIV related patient-reported outcome measures (PROM) and patient-reported experience measures (PREM).
Lohiniva AL; Isosomppi S; Pasanen S; Sutinen J
J Patient Rep Outcomes; 2023 May; 7(1):41. PubMed ID: 37126134
[TBL] [Abstract][Full Text] [Related]
10. Non-disease specific patient-reported outcome measures of health-related quality of life in juvenile idiopathic arthritis: a systematic review of current research and practice.
Młyńczyk J; Abramowicz P; Stawicki MK; Konstantynowicz J
Rheumatol Int; 2022 Feb; 42(2):191-203. PubMed ID: 34971434
[TBL] [Abstract][Full Text] [Related]
11. The Romanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Lazăr C; Iagăru N; Ailioaie C; Ailioaie LM; Laday M; Apostol A; Spîrchez M; Badiu Tișa I; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):331-338. PubMed ID: 29637333
[TBL] [Abstract][Full Text] [Related]
12. The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Consolaro A; Bovis F; Pistorio A; Cimaz R; De Benedetti F; Miniaci A; Corona F; Gerloni V; Martino S; Pastore S; Barone P; Pieropan S; Cortis E; Podda RA; Gallizzi R; Civino A; Torre F; Rigante D; Consolini R; Maggio MC; Magni-Manzoni S; Perfetti F; Filocamo G; Toppino C; Licciardi F; Garrone M; Scala S; Patrone E; Tonelli M; Tani D; Ravelli A; Martini A; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):251-258. PubMed ID: 29637324
[TBL] [Abstract][Full Text] [Related]
13. The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).
Demirkaya E; Ozen S; Sozeri B; Ayaz NA; Kasapcopur O; Unsal E; Makay BB; Barut K; Fidanci BE; Simsek D; Cakan M; Consolaro A; Bovis F; Ruperto N;
Rheumatol Int; 2018 Apr; 38(Suppl 1):395-402. PubMed ID: 29637329
[TBL] [Abstract][Full Text] [Related]
14. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
Barber CEH; Twilt M; Pham T; Currie GR; Benseler S; Yeung RSM; Batthish M; Blanchette N; Guzman J; Lang B; LeBlanc C; Levy DM; O'Brien C; Schmeling H; Soon G; Spiegel L; Whitney K; Marshall DA
Arthritis Res Ther; 2020 Mar; 22(1):53. PubMed ID: 32192528
[TBL] [Abstract][Full Text] [Related]
15. "Asking Too Much?": Randomized N-of-1 Trial Exploring Patient Preferences and Measurement Reactivity to Frequent Use of Remote Multidimensional Pain Assessments in Children and Young People With Juvenile Idiopathic Arthritis.
Lee RR; Shoop-Worrall S; Rashid A; Thomson W; Cordingley L
J Med Internet Res; 2020 Jan; 22(1):e14503. PubMed ID: 32012051
[TBL] [Abstract][Full Text] [Related]
16. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
[TBL] [Abstract][Full Text] [Related]
17. The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis.
Low JM; Hyrich KL; Ciurtin C; McErlane F; Wedderburn LR; Geifman N; Shoop-Worrall SJW;
Rheumatology (Oxford); 2024 May; 63(5):1273-1280. PubMed ID: 37467079
[TBL] [Abstract][Full Text] [Related]
18. Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials.
Sherratt FC; Roper L; Stones SR; McErlane F; Peak M; Beresford MW; Foster H; Ramanan AV; Rooney M; Baildam E; Young B
Pediatr Rheumatol Online J; 2018 Dec; 16(1):76. PubMed ID: 30514320
[TBL] [Abstract][Full Text] [Related]
19. Managing juvenile idiopathic arthritis within the context of their life: What we learnt from children and youth living with juvenile idiopathic arthritis and their parents.
Currie GR; Kennedy BL; S M B; R S M Y; J F S; S J V; N M W; M M A K; MacKean G; Marshall DA
Musculoskeletal Care; 2023 Dec; 21(4):1248-1260. PubMed ID: 37596866
[TBL] [Abstract][Full Text] [Related]
20. Use of Patient-Reported Outcome Measures and Patient-Reported Experience Measures Within Evaluation Studies of Telemedicine Applications: Systematic Review.
Knapp A; Harst L; Hager S; Schmitt J; Scheibe M
J Med Internet Res; 2021 Nov; 23(11):e30042. PubMed ID: 34523604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
